Cargando…

Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin

Ivermectin is an anthelmintic drug that works by inhibiting neuronal activity and muscular contractility in arthropods and nematodes. It works by activating glutamate-gated chloride channels (GluClRs) at nanomolar concentrations. These receptors, found exclusively in invertebrates, belong to the pen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynagh, Timothy, Lynch, Joseph W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345530/
https://www.ncbi.nlm.nih.gov/pubmed/22586367
http://dx.doi.org/10.3389/fnmol.2012.00060
_version_ 1782232143618899968
author Lynagh, Timothy
Lynch, Joseph W.
author_facet Lynagh, Timothy
Lynch, Joseph W.
author_sort Lynagh, Timothy
collection PubMed
description Ivermectin is an anthelmintic drug that works by inhibiting neuronal activity and muscular contractility in arthropods and nematodes. It works by activating glutamate-gated chloride channels (GluClRs) at nanomolar concentrations. These receptors, found exclusively in invertebrates, belong to the pentameric Cys-loop receptor family of ligand-gated ion channels (LGICs). Higher (micromolar) concentrations of ivermectin also activate or modulate vertebrate Cys-loop receptors, including the excitatory nicotinic and the inhibitory GABA type-A and glycine receptors (GlyRs). An X-ray crystal structure of ivermectin complexed with the C. elegans α GluClR demonstrated that ivermectin binds to the transmembrane domain in a cleft at the interface of adjacent subunits. It also identified three hydrogen bonds thought to attach ivermectin to its site. Site-directed mutagenesis and voltage-clamp electrophysiology have also been employed to probe the binding site for ivermectin in α1 GlyRs. These have raised doubts as to whether the hydrogen bonds are essential for high ivermectin potency. Due to its lipophilic nature, it is likely that ivermectin accumulates in the membrane and binds reversibly (i.e., weakly) to its site. Several lines of evidence suggest that ivermectin opens the channel pore via a structural change distinct from that induced by the neurotransmitter agonist. Conformational changes occurring at locations distant from the pore can be probed using voltage-clamp fluorometry (VCF), a technique which involves quantitating agonist-induced fluorescence changes from environmentally sensitive fluorophores covalently attached to receptor domains of interest. This technique has demonstrated that ivermectin induces a global conformational change that propagates from the transmembrane domain to the neurotransmitter binding site, thus suggesting a mechanism by which ivermectin potentiates neurotransmitter-gated currents. Together, this information provides new insights into the mechanisms of action of this important drug.
format Online
Article
Text
id pubmed-3345530
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-33455302012-05-14 Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin Lynagh, Timothy Lynch, Joseph W. Front Mol Neurosci Neuroscience Ivermectin is an anthelmintic drug that works by inhibiting neuronal activity and muscular contractility in arthropods and nematodes. It works by activating glutamate-gated chloride channels (GluClRs) at nanomolar concentrations. These receptors, found exclusively in invertebrates, belong to the pentameric Cys-loop receptor family of ligand-gated ion channels (LGICs). Higher (micromolar) concentrations of ivermectin also activate or modulate vertebrate Cys-loop receptors, including the excitatory nicotinic and the inhibitory GABA type-A and glycine receptors (GlyRs). An X-ray crystal structure of ivermectin complexed with the C. elegans α GluClR demonstrated that ivermectin binds to the transmembrane domain in a cleft at the interface of adjacent subunits. It also identified three hydrogen bonds thought to attach ivermectin to its site. Site-directed mutagenesis and voltage-clamp electrophysiology have also been employed to probe the binding site for ivermectin in α1 GlyRs. These have raised doubts as to whether the hydrogen bonds are essential for high ivermectin potency. Due to its lipophilic nature, it is likely that ivermectin accumulates in the membrane and binds reversibly (i.e., weakly) to its site. Several lines of evidence suggest that ivermectin opens the channel pore via a structural change distinct from that induced by the neurotransmitter agonist. Conformational changes occurring at locations distant from the pore can be probed using voltage-clamp fluorometry (VCF), a technique which involves quantitating agonist-induced fluorescence changes from environmentally sensitive fluorophores covalently attached to receptor domains of interest. This technique has demonstrated that ivermectin induces a global conformational change that propagates from the transmembrane domain to the neurotransmitter binding site, thus suggesting a mechanism by which ivermectin potentiates neurotransmitter-gated currents. Together, this information provides new insights into the mechanisms of action of this important drug. Frontiers Media S.A. 2012-05-07 /pmc/articles/PMC3345530/ /pubmed/22586367 http://dx.doi.org/10.3389/fnmol.2012.00060 Text en Copyright © 2012 Lynagh and Lynch. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.
spellingShingle Neuroscience
Lynagh, Timothy
Lynch, Joseph W.
Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin
title Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin
title_full Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin
title_fullStr Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin
title_full_unstemmed Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin
title_short Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin
title_sort molecular mechanisms of cys-loop ion channel receptor modulation by ivermectin
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345530/
https://www.ncbi.nlm.nih.gov/pubmed/22586367
http://dx.doi.org/10.3389/fnmol.2012.00060
work_keys_str_mv AT lynaghtimothy molecularmechanismsofcysloopionchannelreceptormodulationbyivermectin
AT lynchjosephw molecularmechanismsofcysloopionchannelreceptormodulationbyivermectin